Tokyo, March 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061074) titled 'Multicenter Study on Quality Of Life and Treatment Compliance in Patients with Chronic Hepatitis B' on March 27.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - Hepatitis B
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluate differences in health-related quality of life (HRQOL) based on the use and type of nucleoside/nucleotide analog agents among patients with chronic hepatitis B virus (HBV) infection.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (1) Disease Name: Hepatitis B virus carrier, chronic hepatitis B, hepatitis B cirrhosis
(2) Regardless of disease stage
(3) Individuals who have provided appropriate consent for study participation
Key exclusion criteria - None
Target Size - 2000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 01 Month 05 Day
Date of IRB - 2026 Year 02 Month 17 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069404
Disclaimer: Curated by HT Syndication.
